Topical capsaicin in the management of HIV-associated peripheral neuropathy

Journal of Pain and Symptom Management

Volumn 19, Issue 1, 2000, Pages 45-52

  Paice, Judith A ^a   Ferrans, Carol Estwing ^c   Lashley, Felissa R ^e   Shott, Susan ^b   Vizgirda, Vida ^c   Pitrak, David ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF ILLINOIS   (United States)

^e SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

Capsaicin; HIV; Pain; Peripheral neuropathy

Indexed keywords

CAPSAICIN; UNCLASSIFIED DRUG; ZOTRIX HP;

ADULT; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM;

ADMINISTRATION, TOPICAL; ADULT; CAPSAICIN; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PERIPHERAL NERVOUS SYSTEM DISEASES; TREATMENT FAILURE;

EID: 0033972417     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(99)00139-6     Document Type: Article

References (43)

1. Breitbart W, Rosenfeld BD, Passik SD, McDonald MV, Thaler H, Portenoy RK. The undertreatment of pain in ambulatory AIDS patients. Pain 1996;65:243-249.
2. Lebovits AH, Lefkowitz M, McCarthy D, Simon R, Wilpon H, Jung R, Fried E. The prevalence and management of pain in patients with AIDS: A review of 134 cases. Clin J Pain 1989;5:245-248.
3. McCormack JP, Li R, Zarowny D, Singer J. Inadequate treatment of pain in ambulatory HIV patients. Clin J Pain 1993;9:279-283.
4. Hewitt DJ, McDonald M, Portenoy RK, Rosenfield B, Passik S, Breitbart W. Pain syndromes and etiologies in ambulatory AIDS patients. Pain 1997;70:117-123.
5. Newshan GT, Wainapel SF. Pain characteristics and their management in persons with AIDS. JANAC 1993;4:53-59.
6. Singer EJ, Zorilla C, Fahy-Chandon B, Chi S, Syndulko K, Tourtellotte WW. Painful symptoms reported by ambulatory HIV-infected men in a longitudinal study. Pain 1993;54:15-19.
7. Hall CD, Snyder CR, Messenheimer JA, Wilkins JW, Robertson WT, Whalely RA, Robertson KR. Peripheral neuropathy in a cohort of human immunodeficiency virus-infected patients: Incidence and relationship to other nervous system dysfunction. Arch Neurol 1991;48:1273-1274.
8. Berger AR, Arezzo JC, Schaumburg HH, Skowron G, Merigan T, Bozzette S, Richman D, Soo W. 2′,3′-Dideoxycytidine (ddC) toxic neuropathy: A study of 52 patients. Neurology 1993;43:358-362.
9. Gulevich SJ, Kalmijn JA, Thal LJ, Iragui-Madoz V, McCutchan JA, Kennedy C, Grant I, And the HIV Neurobehavioral Research Center Group. Sensory testing in human immunodeficiency virus type 1-infected men. Arch Neurol 1992;49:1281-1284.
10. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Def Syndr Human Retrovirol 1995;9:379-388.
11. Penfield J, Clark AJM. Pain syndromes in HIV infection. Can J Anaesth 1992;39:724-730.
12. Fuller GN, Jacobs JM, Guiloff RJ. Nature and incidence of peripheral nerve syndromes in HIV infection. J Neurol Neurosurg Psychiatry 1993;56:372-381.
13. 12 metabolism in human immunodeficiency virus infection: Association with neurological dysfunction. Arch Neurol 1991;48:312-314.
14. Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical Practice Guideline No. 9. ACHPR Publication No. 94-0592. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, 1994.
15. Simpson DM, Olney RK. Peripheral neuropathies associated with human immunodeficiency virus infection. Neurol Clin 1992;10:685-711.
16. Szallasi A, Goso C. Characterization by [3H] resiniferatoxin binding of a human vanilloid (capsaicin) receptor in post-mortem spinal cord. Neurosci Let 1994;165:101-104.
17. Caterina M, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997;389:816-824.
18. Lynn B. Capsaicin: Actions on the nociceptive C-fibres and therapeutic potential. Pain 1990;41:61-69.
19. Marsh SJ, Stansfeld CE, Brown DA, Davey R, McCarthy D. The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience 1987;23:275-289.
20. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-768.
21. Nolano M, Simone DA, Wendelschafer-Crabb G, Kennedy WR. Decreased sensation and loss of epidermal nerve fibers following repeated topical application of capsaicin in humans. Society for Neuroscience 1996;22:1802 (Abstract 709.2).
22. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, Albert D, Renold F. Treatment of arthritis with topical capsaicin: A double-blind trial. Clin Ther 1991;13:383-395.
23. Watson CPN, Evans RJ, Watt VR. Post-herpetic neuralgia and topical capsaicin. Pain 1988;33:333-340.
24. Bernstein JE, Bickers DR, Dahl MV, Roshal JY. Treatment of chronic postherpetic neuralgia with topical capsaicin. J Am Acad Dermatol 1987;17:93-96.
25. Peikert A, Hentrich M, Ochs G. Topical 0.025% capsaicin in chronic post-herpetic neuralgia: Efficacy, predictors of response and long-term course. J Neurol 1991;238:452-456.
26. Capsaicin Study Group. Treatment of painful diabetic neuropathy with topical capsaicin: A multicenter, double-blind, vehicle-controlled study. Arch Intern Med 1991;151:2225-2229.
27. Scheffler NM, Sheitel PL, Lipton MN. Treatment of painful diabetic neuropathy with capsaicin 0.075%. J Am Pod Med Assoc 1991;81:288-289.
28. Chad DA, Aronin N, Lundstrom R, McKeon P, Ross D, Molitch M, Schipper HM, Stall G, Dyess E, Tarsy D. Does capsaicin relieve the pain of diabetic neuropathy? Pain 1990;42:387-388.
29. Watson CPN, Evans RJ, Watt VR. The postmastectomy pain syndrome and the effect of topical capsaicin. Pain 1989;38:177-186.
30. Watson CPN, Evans RJ. The postmastectomy pain syndrome and topical capsaicin: A randomized trial. Pain 1992;51:375-379.
31. Ellison N, Loprinzi CL, Kugler J, Hatfield AK, Miser A, Sloan JA, Wender DB, Rowland KM, Molina R, Cascino TL, Vukov AM, Dhaliwal HS, Ghosh C. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol 1997;15:2974-2980.
32. Low PA, Opfer-Gehrking TL, Dyck PJ, Litchy WJ, O'Brien PC. Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathy. Pain 1995;62:163-168.
33. Daut RL, Cleeland CS, Flanery RC. Development of the wisconsin brief pain questionnaire to assess pain in cancer and other diseases. Pain 1983;17:197-210.
34. Breitbart W, Rosenfeld BD, Passik SD, Kaim M, Funesti-Esch J, Stein K. A comparison of pain report and adequacy of analgesic therapy in ambulatory AIDS patients with and without a history of substance abuse. Pain 1997;72:235-243.
35. Larue F, Fontaine A, Colleau SM. Underestimation and undertreatment of pain in HIV disease: Multicentre study. Br Med J 1997;314:23-28.
36. Ferrans C. Development of a quality of life index for patients with cancer. Oncol Nurs Forum 1990;17(3 suppl):15-19.
37. Ferrans C, Powers M. Psychometric assessment of the quality of life index. Res Nurs Health 1992;15:29-38.
38. Anderson J, Ferrans C. The quality of life of persons with chronic fatigue syndrome. J Nerv Mental Dis 1997;186:359-367.
39. Shacham S. A shortened version of the profile of mood states. J Pers Assess 1983;47:304-305.
40. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: Development and final revision of a health status measure. Med Care 1981;19:787-805.
41. Holewski JJ, Stess RM, Graf PM, Grunfeld C. Aesthesiometry: Quantification of cutaneous pressure sensation in diabetic peripheral neuropathy. J Rehab Res Dev 1988;25:1-10.
42. Breitbart W, McDonald MV, Rosenfeld B, Passik SD, Hewitt D, Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates. Pain 1996;68:315-321.
43. Rosenfeld B, Breitbart W, McDonald MV, Passik SD, Thaler H, Portenoy RK. Pain in ambulatory AIDS patients. II: Impact of pain on psychological functioning and quality of life. Pain 1996;68:323-328.